Since then, anti-TNF inhibitors have been largely used for the treatment of RA and other inflammatory diseases and become blockbuster drugs, giving profits of over 20 million dollars worldwide in 2020 [5]. The gene discussed is TNF; the disease is rheumatoid arthritis.